Nonrandom chromosome abnormalities in cancer: An overview

Sverre Heim, Felix Mitelman

Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

Abstract

This chapter discusses neoplastic karyotypes. It emphasizes the difference between primary and secondary changes and address the questions of why, how, when, and where chromosome abnormalities arise; compare numerical and structural aberrations in terms of how they contribute to tumor development; and also touch upon the issues of what causes cancer-associated chromosome abnormalities and whether they are necessary and/or sufficient to transform a normal cell into a cancer cell. It discusses some of the more principal differences between the cytogenetic and molecular genetic approaches to the study of acquired somatic cell mutations. Numerous specific chromosomal abnormalities have been detected in almost all tumor types that have been examined. This chapter explores when do chromosome aberrations arise and in which cells do chromosome aberrations arise. It also discusses whether acquired chromosome aberrations are sufficient for neoplastic proliferation. The chapter discusses the general effects of structural and numerical chromosome abnormalities.

Original languageEnglish
Title of host publicationCancer Cytogenetics
Subtitle of host publicationChromosomal and Molecular Genetic Aberrations of Tumor Cells
EditorsSverre Heim, Felix Mitelman
PublisherWiley-Blackwell
Pages26-41
Number of pages16
Edition4th
ISBN (Electronic)9781118795569
ISBN (Print)9781118795538
DOIs
Publication statusPublished - 2015

Subject classification (UKÄ)

  • Medical Genetics

Free keywords

  • Cancer-associated chromosome abnormalities
  • Chromosome aberrations
  • Neoplastic karyotypes
  • Numerical chromosome abnormalities
  • Tumor development

Fingerprint

Dive into the research topics of 'Nonrandom chromosome abnormalities in cancer: An overview'. Together they form a unique fingerprint.

Cite this